“chiasma” Archives

in
Entry Author Date Location
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
Rare Drug Developer Chiasma Lays Off More Workers After FDA Impasse 08/16/16 Boston
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Boston-Israel Connection Rising: 200-Plus Firms, 9K Jobs, $9B Sales 06/08/16 Boston
Chiasma Shares Crater as FDA Rejects Hormone Drug, Asks For More Data 04/18/16 Boston
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Rapid7 Prices IPO at $16 Per Share as Cybersecurity Takes Center Stage 07/16/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
Chiasma Seeks $75 Million and FDA Approval for Acromegaly Orphan Drug 07/06/15 Boston
Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News 07/06/11 Boston
Chiasma Secures $5,115,000 New Financing Round 07/01/11 Boston
Chiasma Obtains $1,000,000 New Round 06/15/11 Boston
Chiasma Receives $4,000,000 New Financing 03/09/11 Boston
Chiasma Secures $3,000,000 New Financing Round 01/06/11 Boston
Page 1 of 1